Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
---|
05/11/2006 | CA2585462A1 Methods of generating antigen-specific cd4+cd25+ regulatory t cells, compositions and methods of use |
05/11/2006 | CA2559275A1 Autogenic living scaffolds and living tissue matrices: methods and uses thereof |
05/10/2006 | EP1655607A1 Lawsonia intracellularis cultivation, anti-lawsonia intracellularis vaccines and diagnostic agents |
05/10/2006 | EP1655382A2 Colon specific gene and protein |
05/10/2006 | EP1655370A1 Bacterial vector |
05/10/2006 | EP1655369A1 Diagnosis and treatment of AUR-1 and/or AUR-2 related disorders |
05/10/2006 | EP1655368A1 Vascular endothelial cell growth factor variants and uses thereof |
05/10/2006 | EP1655367A1 Modulators of tissue regeneration |
05/10/2006 | EP1655305A2 Therapeutic anti-cytomegalovirus compounds |
05/10/2006 | EP1654537A2 Tssk4: a human testis specific serine/threonine kinase |
05/10/2006 | EP1654378A2 Methods for chemically synthesizing immunoglobulin chimeric proteins |
05/10/2006 | EP1654377A2 Shc PROTEIN-RELATED METHODS AND COMPOSITIONS FOR THE PROGNOSIS OF BREAST, PROSTATE AND OVARIAN CANCER |
05/10/2006 | EP1654366A1 Stem cell beacon |
05/10/2006 | EP1654365A1 Vigilant cells |
05/10/2006 | EP1654359A2 Synthetic nucleic acids from aquatic species |
05/10/2006 | EP1654353A2 Tumour cell lines nm-f9 (dsm acc2606) and nm-d4 (dsm acc2605), uses threreof |
05/10/2006 | EP1654352A1 Reversibly immortalised olfactory ensheathing glia and their use to promote neuronal regeneration |
05/10/2006 | EP1654351A1 Method of generating neural stem cells |
05/10/2006 | EP1654346A2 Method and system for the analysis of high density cells samples |
05/10/2006 | EP1654285A2 Amino acid sequences facilitating penetration of a substance of interest into cells and/or cell nuclei |
05/10/2006 | EP1653989A2 Anti-bacterial composition, especially for controlling gram-negative bacteria, comprising a peptide and an advantageously hydrophobic anti-bacterial agent |
05/10/2006 | EP1653979A1 Compositions containing macrophages and uses thereof |
05/10/2006 | EP1653912A2 Vaccine immunotherapy for immune suppressed patients |
05/10/2006 | EP1653808A1 Neurogenin3 and production of pancreatic islet cells |
05/10/2006 | EP1653807A2 Dermal micro organs, methods and apparatuses for producing and using the same |
05/10/2006 | EP1624899A4 Increased transduction using abc transporter substrates and/or inhibitors |
05/10/2006 | EP1539784A4 Chitinase encoding dna molecule from cotton expressed preferentially in fibers during secondary cell wall deposition and the corresponding promoter |
05/10/2006 | EP1509598A4 Induction of insulin expression |
05/10/2006 | EP1483374B1 Use of l-alpha-lysophosphatidycholine to obtain the differentiation of monocytes in mature dendritric cells in vitro |
05/10/2006 | EP1432991A4 Identification and isolation of somatic stem cells and uses thereof |
05/10/2006 | EP1392859B1 Isolating cells expressing secreted proteins |
05/10/2006 | EP1320609B1 Isolated peptides which bind to hla-c molecules and uses thereof |
05/10/2006 | EP1282641B1 Human cervical cancer suppressor protein, polynucleotide encoding the protein, cell transformed with the polynucleotide and method for suppressing proliferation of cancer cell using the expression vector |
05/10/2006 | EP1185297B1 Streptococcus pneumoniae proteins and vaccines |
05/10/2006 | EP1126859B1 Blood leucocyte apheresis for treatment of hiv |
05/10/2006 | EP1081223B1 Promoter sequences expressed in anthers and pollens |
05/10/2006 | EP1062351B1 Novel plant plastid promoter sequence |
05/10/2006 | EP1006782B1 Polypeptides fused with alfalfa mosaic virus or ilarvirus capsid |
05/10/2006 | EP0988389B1 Method for the production of non-group c adenoviral vectors |
05/10/2006 | EP0960129B1 MELATONIN 1a RECEPTOR GENE REGULATORY REGIONS AND USES THEREOF |
05/10/2006 | EP0957161B1 Method for activating human antigen presenting cells, activated human antigen presenting cells, and use of the same |
05/10/2006 | EP0873049B1 Methods for enhanced virus-mediated dna transfer using molecules with virus- and cell-binding domains |
05/10/2006 | EP0870839B1 Method for gene introduction into target cells by retrovirus |
05/10/2006 | EP0721505B2 Purified hepatitis c virus envelope proteins for diagnostic and therapeutic use |
05/10/2006 | CN1771324A High-expression vector for animal cells |
05/10/2006 | CN1771261A Antibodies against insulin-like growth factor I receptor and thereof |
05/10/2006 | CN1770976A Use of umbilical cord blood to treat individuals having a disease, disorder or condition |
05/10/2006 | CN1770975A Method of promoting cell viability |
05/10/2006 | CN1769467A Rice new species breeding selection method utilizing double induction and cross breeding |
05/10/2006 | CN1769461A Shenzhen No.5 flameray gerbera transgene technology |
05/10/2006 | CN1769444A Method for obtaining Tibetan Sinopodophyllum hexandrum hairy root which produce podophyllotoxin through agrobacterium rhizogenes genetic transformation, and its product |
05/10/2006 | CN1769441A Polyploid breeding method for inducing heterogenous tripoid scallop by physical means |
05/10/2006 | CN1769432A Ouiescent cell populations for nuclear transfer |
05/10/2006 | CN1769431A Ouiescent cell populations for nuclear transfer |
05/10/2006 | CN1769430A Conditioned medium and diffusible biological product produced by incubating entrapped cells |
05/10/2006 | CN1769429A Method for preparing chimera through Japanese sea perch embryo stem cell transplantation |
05/10/2006 | CN1769428A Hot pepper free spore cell assemblies culture method |
05/10/2006 | CN1768856A Method for preparing injection for removing wrinkles and scars |
05/10/2006 | CN1768759A Nkt cell-activating agents containing alpha-glycosylceramides |
05/10/2006 | CN1768564A Manufactured seed having a live end seal |
05/10/2006 | CN1255544C Fusion polynucleotide fusion polypeptide pessessing salt resistance character and expression carrier |
05/10/2006 | CN1255541C Fatty acyl-CoA: fatty alcohol acyltransferases |
05/10/2006 | CN1255540C Vaccine-induced hepatitis B viral strain and uses thereof |
05/10/2006 | CN1255539C Pesticidal proteins and strains |
05/10/2006 | CN1255538C Rice coronal root control gene CRL3 and its use |
05/10/2006 | CN1255531C Method for configurating feeder-layer-free corneal epithelium for frost self-corneal limbus stem cell |
05/10/2006 | CN1255530C Cholesterol biotransformation method employing resting cell in cloud point system |
05/09/2006 | US7041887 Hybrid maize 33D63 |
05/09/2006 | US7041884 Inbred maize line 291B |
05/09/2006 | US7041883 Potato cultivar FL 2048 |
05/09/2006 | US7041881 Soybean cultivar S030150 |
05/09/2006 | US7041880 relates to seeds of soybean cultivar 0491712, plants of soybean 0491712 and to methods for producing a soybean plant by crossing soybean 0491712 with itself or another soybean line, and the creation of variants by mutagenesis or transformation of soybean 0491712; lodging resistance |
05/09/2006 | US7041876 Nucleotide sequences for use in the generation of disease resistant plants |
05/09/2006 | US7041872 Nucleotide sequences coding enzymatic polypeptide for use in the generation of vegetable oils |
05/09/2006 | US7041871 transgenic mouse comprising in its genome a human kappa light chain immunoglobulin transgene containing five human light chain V kappa segments, L15, L18, L24, A10 and A27, a plurality of human light chain J kappa segments, and human light chain C kappa segment linked to transcription regulatory sequence |
05/09/2006 | US7041870 Transgenic mammal for use in the treatmnent of cardiovascular, infections, cancer and autoimmune disorders |
05/09/2006 | US7041815 Sporamin promoter and uses thereof |
05/09/2006 | US7041813 Canine herpes virus alpha transinducing factor nucleic acid molecules |
05/09/2006 | US7041806 Netrin receptors |
05/09/2006 | US7041802 Peptidoglycan recognition proteins |
05/09/2006 | US7041796 C3b/C4b Complement Receptor-like molecules and uses thereof |
05/09/2006 | US7041788 Multimerized highly functional antifreeze protein |
05/09/2006 | US7041653 Gene transcription and ionizing radiation: methods and compositions |
05/09/2006 | US7041651 Cellular uptake of bioactive agents |
05/09/2006 | US7041634 Method of inhibiting immune system destruction of transplanted viable cells |
05/09/2006 | US7041507 transfecting epidermal basal cells in vitro with a eukaryotic expression vector containing a cDNA encoding a human neurogenic transcription factor; growing with an antisense oligonucleotide comprising a segment of a human MSX1 gene and/or human HES1 gene; growing with a retinoid and a signal molecule |
05/09/2006 | US7041506 Fibronectins; fibroblast growth factors |
05/09/2006 | US7041505 Multicompartment apparatus comprising porous membrane and alginic acid gel layer for propagation of tissues |
05/09/2006 | US7041504 Cancer cell-inhibiting culture medium produced by culturing restricted entrapped cancer cells |
05/09/2006 | US7041503 Modified myelin basic protein molecules |
05/09/2006 | US7041502 Immunology active materials; complexing to major histocompatibility complex |
05/09/2006 | US7041501 Methods of screening for toxicity of test compounds |
05/09/2006 | US7041500 Insect cell line |
05/09/2006 | US7041499 Immuno activation of CS1 receptor in natural killer cells to inhibit tumor cell growth |
05/09/2006 | US7041498 Method for modulating processes mediated by farnesoid activated receptors |
05/09/2006 | US7041497 Used in regulation of genes for tissue inflammation, cellular proliferation, differentiation |
05/09/2006 | US7041496 Nucleotide sequences coding polypeptide for use in the treatment of ataxia, alzheimer's, parkinson's, learning defects, nervous system, epilepsy and stroke disorders |
05/09/2006 | US7041494 DNA encoding Slo2 and Slo4, potassium channel |
05/09/2006 | US7041491 NOD nucleic acids and polypeptides |
05/09/2006 | US7041486 Enzyme having decolorizing activity and method for decolorizing dyes by using the same |